July 07, 2020
Read the full story at: https://www.courthousenews.com/covid-19-imperils-aids-progress-un-warns/
Institute of Human Virology
Chief Communications & Public Affairs Officer
(443) 823-0613 (phone)
(410) 706-1952 (fax)
Tuesday, January 31, 2023
University of Maryland School of Medicine’s Institute of Human Virology Director Dr. Robert Gallo Co-Authors STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19
STAT today published "How the Biden administration’s Covid preparedness policies could narrow America’s political divide" co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some animals. The opinion piece calls on the Biden Administration to “follow the science” in updating COVID-19 preparedness policies to align with the indefinite endemic phase the country is now facing.
Wednesday, January 18, 2023
BBC: The scientist who smuggled HIV in her bag into her country to study it and save lives
Acquired immune deficiency syndrome, AIDS, had been recognized as a new disease in 1981, when an increasing number of young homosexuals died of unusual infections and rare cancers. It was also known to affect intravenous drug users and some were known to have contracted it through blood transfusions.
Friday, January 06, 2023
USA Today: Fact check: Research proves HIV is the cause of AIDS, contrary to viral claim
The claim: There is no proof HIV is the cause of AIDS. A Dec. 15 Facebook video shows Kary Mullis, a scientist known for denying the link between HIV and AIDS, claiming again there is no proof HIV is the cause of AIDS. The post was shared more than 1,000 times in a week. The clip comes from a 2009 documentary that promoted AIDS denialism, which has more than 300,000 views on YouTube.
Wednesday, December 21, 2022
Lead Stories: Fact Check: Doctor Did NOT Say On Video That He Manufactured AIDS As Bio Weapon -- This Is A Soviet-Era Disinformation Hoax
Did an American doctor admit on video that he created the HIV and AIDS viruses in a U.S. military medical laboratory, Fort Detrick, so that they could be used as biological weapons for depopulating the world? No, that's not true: Dr. Robert Gallo, the doctor featured in the video, makes no such admission in the footage, and told Lead Stories that his scientific work was not part of any plan to weaponize HIV/AIDS. Historical records show that the claim is a well-documented hoax that dates to a Soviet disinformation campaign from the 1980s.
Thursday, December 01, 2022
Everyday Health: 10 Facts About HIV/AIDS Everyone Should Know
A basic understanding of HIV and AIDS can help dispel the myths, erase stigma, prevent virus transmission, and save lives — beginning with your own.
Wednesday, November 30, 2022
World AIDS Day: IHV’s International Leadership in Combatting AIDS
Each year, World AIDS Day is held on December 1 as an opportunity to unite in solidarity for the fight against HIV, honor people living with HIV, and those lost to an HIV/AIDS-related illness. The Institute of Human Virology (IHV), and particular, its Founder and Co-Director Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, and its many members have made many contributions and advancements towards preventing, treating, and developing a cure for HIV.
Wednesday, September 28, 2022
TheBody: What Is HIV Remission?
A cure for HIV remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing. But what exactly is remission? Can HIV go into remission? And how does it differ from a cure? Generally, remission means that a disease has stopped being active but hasn’t necessarily been eliminated.
Wednesday, September 21, 2022
Baltimore Fishbowl: ‘AIDS ain’t over’: Supporters look back on 35 years at AIDS Action Baltimore
Six people were honored on Sunday for their support of AIDS Action Baltimore, as it marks its 35th anniversary. More than 150 people gathered at The Belvedere to mark the occasion and pay tribute to the honorees and executive director Lynda Dee.
Monday, September 19, 2022
TheBody: HIV Seroconversion: Timeline, Symptoms, Testing, and Treatment
There are several stages of HIV infection—from the initial exposure to the virus to the development of AIDS—but a lot of important changes happen during the earliest stage: seroconversion. So, exactly what is HIV seroconversion? It is the stage in which the immune system first starts to make antibodies to try to fight HIV after exposure. Once detectable levels of antibodies are produced, this is described as seroconversion.
Monday, September 19, 2022
TheBody: What Are the Chances of Getting HIV from One Exposure?
You had a one-night stand with someone of questionable HIV status. Now the panic begins. Could you have HIV after only one exposure? What are the odds?
Wednesday, August 17, 2022
Africa Defense Forum: Study: COVID-19 Bigger Risk For Pregnant Women
Pregnant women who catch COVID-19 are in much greater danger than previously suspected, according to a new study that analyzed data collected from six African countries.
Wednesday, August 17, 2022
Popular Science: As COVID vaccines reach kids worldwide, a gap in Africa leaves everyone exposed
Many African countries have fallen behind on delivering COVID shots to kids, despite a higher risk of severe sickness in a massively young population.
Tuesday, May 31, 2022
Medscape: Fatigue Affects Cognitive Processing Speed in the Aging HIV Population
Successful aging is something that most of us strive for. But with aging comes a pervasive condition called fatigue that, in many older adults, interferes with everyday functioning, mental health, social support, and overall quality of life. The relationship between fatigue and cognitive and functional impairment is one of particular interest in people living with HIV (PWH), a patient population that is disproportionately affected but whose lifespan now matches that of the general population.
Friday, May 20, 2022
NIH Grant Awarded to Study HIV Drug-Resistant Genetic Mutations Across Africa
University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy. The study, named INSPIRE, will analyze genetic variation in types of HIV circulating in a handful of African countries that will help to better understand the implications of these mutations and will improve clinical management of patients.
Thursday, May 19, 2022
Baltimore Sun: With COVID cases rising, you’re still not fully vaxxed or boosted? Come on now.
Dan Rodricks: I recently had conversations with a middle-aged man who is extremely careful about what he puts into his body. He eats lots of fruits and vegetables and stays away from red meat and processed foods. He also refuses to get the vaccine against COVID-19, even as infections are on the rise again.
Tuesday, May 10, 2022
Medscape: Decentralizing PrEP Offers a Roadmap for Retention
Good solutions have great roadmaps. For HIV preexposure prophylaxis (PrEP), the road map might just be that of contraceptive care. Once an onerous process, over time contraceptive care exploded into a range of options across a broad landscape in terms of approach and accessibility. How then do organizations help vulnerable patients navigate their PrEP journeys using the contraceptive roadmap as a guide?
Tuesday, April 19, 2022
Quartz: Poor countries got screwed on COVID vaccines. They’re making sure it won’t happen again
Since early on, the pandemic has highlighted inequality both on a micro scale—within countries, between social classes and ethnic groups—and a macro one—between rich and poor countries. It also confirmed what many of those working in global health—particularly in and for low- and middle-income countries—expected: In an emergency, no matter the declared values and intention, people will first and foremost, and in many cases only, care about themselves and their own.
Friday, March 18, 2022
Deutsche Presse-Agentur: Virus hunt for decades: US researcher Robert Gallo turns 85
Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.
Thursday, March 10, 2022
Healthline: HIV-1 May Be More Virulent When Transmitted Through Penile-Vaginal Intercourse
HIV-1 can be transmitted through vaginal, anal, and oral sex, whether it’s with a same-sex or different-sex partner. But the risk of developing it seems to vary depending on how the disease is transmitted. In fact, the HIV virus may be more virulent when passed between male and female partners who have penile-vaginal sex than among men who have anal sex with other men, according to a new study from the Indian Institute of Science.
Thursday, March 10, 2022
HIV Plus: One Woman Shares Her Journey of Living with HIV for Over Three Decades
In honoring long-term survivors and National Women and Girls HIV Awareness Day on March 10, I had the opportunity to speak with Ms. Kathy Bennett. She is a 63-year-old Black woman who has been living with HIV for over 31 years. She recently led the longest running HIV support group in Maryland.
Friday, March 04, 2022
The Atlantic: The Pandemic Is Following a Very Predictable and Depressing Pattern
Americans, by and large, are putting the pandemic behind them. Now that Omicron is in the rearview mirror and cases are plummeting, even many of those who have stayed cautious for two full years are spouting narratives about “going back to normal” and “living with COVID-19.” But in the global South, COVID-19 is much harder to ignore. More than a year after the start of the mass-vaccination campaign, nearly 3 billion people are still waiting for their first shot.
Wednesday, February 23, 2022
TIME: Knowing the Origins of COVID-19 Won't Change Much
Over two years since the first cases started appearing in Wuhan, China, there is much we don’t know about the origins of SARS-CoV-2, the virus causing COVID-19. But a quick resolution to that question is possible: scientists could find bats in a cave somewhere in China or in southeast Asia and trace a chain leading from those bats to the COVID-19 outbreak in Wuhan. Realistically, however, recent history offers little promise for this to happen quickly.
Wednesday, February 16, 2022
WBAL: Maryland HIV researcher on latest research: It's not a cure
Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.
Tuesday, February 08, 2022
The New Yorker: Beyond the Booster Shot
Could a “broad spectrum” booster increase our immunity to many pathogens simultaneously? The first tuberculosis vaccine was developed in 1921, by two French scientists, Albert Calmette and Camille Guérin. It was called Bacillus Calmette-Guérin, or B.C.G., and has long been one of the world’s most widely administered shots. From the beginning, its power was surprising. B.C.G. contains a bacterium similar to the one that causes TB, and engenders an immune defense specific to that disease. But, as Calmette noted in a paper in 1931, those vaccinated with B.C.G. at birth were around seventy-five per cent less likely to die in their early years of any cause.
Monday, February 07, 2022
The GW Hatchet: University administers first doses of mRNA HIV vaccine through Moderna partnership
GW was one of the first institutions in the country to administer doses of the first mRNA HIV vaccines to human test subjects late last month. The School of Medicine and Health Sciences and its Vaccine Research Unit collaborated with Moderna to test the safety of the vaccine and the immune responses of two participants in the phase 1 clinical trial.
Friday, February 04, 2022
WYPR: How the COVID pandemic rattled HIV testing
The COVID pandemic did not end the HIV-AIDS epidemic; it may have obscured it for a while, raising hurdles to getting tested for HIV.
Friday, January 28, 2022
The Washington Post: COVID-19 may have seasons for different temperature zones, study suggests
COVID-19 transmission may have seasonal spikes tied to temperature and humidity, increasing at different times of the year for different locations, a new study in the American Journal of Tropical Medicine and Hygiene suggests.
Wednesday, January 26, 2022
STAT: Early research suggests cancer drug could help flush HIV from its hiding spots
In a study published Wednesday in Science Translational Medicine, researchers looked at 32 patients that had both cancer and HIV and found that pembrolizumab, which revives the immune system and encourages it to attack tumors, also has the ability to flush HIV out of its hiding spot in immune cells.
Tuesday, January 25, 2022
Baltimore Sun: Doctors in Maryland see COVID treatments aiding return to more normal life, once the public can get them
The focus is increasingly on preventing hospitalizations and deaths, rather than stopping all COVID-19 infections, by using new therapies.
Monday, January 10, 2022
Yahoo! Finance: Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
Although recent oral antiviral drugs have been approved by the FDA, the Company believes that Tempol would provide an unmet medical need because of its unique mechanism of action and safety profile.
Wednesday, December 22, 2021
Washington Post: Remdesivir can help keep unvaccinated, high-risk people with covid-19 out of hospitals, study finds
The antiviral drug remdesivir can help keep unvaccinated people at risk of severe covid-19 out of hospitals, according to a study that found the treatment reduced hospitalization and death by 87 percent when given soon after diagnosis.
Thursday, December 16, 2021
Ren TV (Russia): Virologist who discovered HIV urged to vaccinate children
Robert Gallo, director and co-founder of the Institute of Human Virology at the University of Maryland and co-founder of the Global Virus Network, discussed why it is important to vaccinate children against coronavirus.
Wednesday, December 15, 2021
Conversations on Health Care: Robert Gallo, Scientist Who Co-Discovered HIV Offers Guidance to Patients as Omicron Increases
Dr. Gallo says their network of scientists knew early in the COVID-19 pandemic that the mRNA vaccines would be effective, but for a limited time, and that boosters will be required until the global outbreak is brought under control. He says it’s too soon to predict the full impact of the omicron variant, but that it is likely to overwhelm many countries.
Monday, December 13, 2021
Reuters Health via Medscape: Passive Exposure to Oral Polio Vaccine May Protect Against COVID-19 for at Least 6 Months
Mothers of children immunized with the oral polio vaccine, which is made from a live attenuated virus, seemed to be protected against symptomatic COVID-19 for at least six months based on a study in Iran.
Wednesday, November 10, 2021
Omaha World-Herald: UNMC researchers develop 'molecular scissors' to target HIV
Researchers at the University of Nebraska Medical Center have used a new method they’re calling a “molecular scissors” to nearly eliminate HIV embedded in the genetic material of human cells.
Tuesday, November 02, 2021
CNN: Johnson & Johnson's Covid-19 vaccine is 73.6% effective, according to new real-world study
In an accompanying commentary, Dr. Mohammad Sajadi of the Institute of Human Virology at the University of Maryland School of Medicine, argued that the findings are part of a growing body of work that suggests "room for improvement" with the J&J vaccine.
Tuesday, October 26, 2021
Correio Braziliense: "It's obvious that no vaccine causes AIDS," says one of the virologists who discovered HIV
The virologist, and one of the discoverers of HIV, speaks to Correio about statements by President Bolsonaro live on social media
Friday, October 22, 2021
Healthline: Why Unvaccinated People Are Being Denied Organ Transplants
Experts say there are a number of reasons they prefer organ transplant recipients receive vaccinations against COVID-19 as well as other diseases before surgery.
Friday, October 15, 2021
WebMD: Vaccine hesitancy has always been around
Even as the fourth wave of COVID-19 cases trends downward, one aspect of the pandemic remains strong: differing opinions on the value of COVID-19 immunization and vaccine mandates across the U.S.
Thursday, September 02, 2021
Yahoo! Finance: Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19
Adamis Pharmaceuticals Corporation announced the initiation of patient dosing in the Phase 2/3 clinical trial for Tempol, an oral antiviral product candidate, in adult patients with confirmed COVID-19 infection. In preclinical studies, Tempol has been shown to have antiviral, anti-inflammatory and antioxidant activity.
Monday, August 16, 2021
Maryland Public Television: On Who Needs COVID Booster Shots
Dr. Katya Prakash-Haft discusses why organ transplant recipients and other immune compromised people need COVID booster shots
Friday, August 13, 2021
WMAR: CDC Recommends Third Shot for Immunocompromised Americans
The federal agency’s decision follows the FDA’s move to authorize the additional shot of the Pfizer and Moderna vaccine. It comes after research has shown the vaccine isn’t as effective for immunocompromised people compared to the general population.
Tuesday, July 27, 2021
The Chronicle of Higher Education: New CDC Mask-Wearing Guidance Could Alter Colleges’ Return-to-Campus Plans
The Centers for Disease Control and Prevention updated its guidance on Tuesday, recommending that vaccinated Americans wear masks indoors in certain circumstances due to the highly transmissible Delta variant of Covid-19. This may throw a wrench in return-to-campus plans for colleges that aimed to resume pre-pandemic operations.
Monday, July 26, 2021
WJLA: Amid virus surge, Fauci says some might 'likely' need booster shots
As COVID-19 cases surge and the highly infectious delta variant spreads across the United States, drugmakers and federal health officials remain divided over when and if people who have been vaccinated might need booster shots to bolster their immunity.
Friday, July 23, 2021
Newswise: COVID Variants and a Surge Among the Unvaccinated
Panelists will discuss the threat posed by new COVID variants and continued vaccine hesitancy.
Friday, July 23, 2021
WUSA: VERIFY: Here's a look at Japan's vaccination plan
People online claim the Olympics are in jeopardy because the country has no plan to vaccinate its population. That's false.
Tuesday, July 20, 2021
Nature: Should children get COVID vaccines? What the science says
With vaccination campaigns underway in some countries while others weigh the options, Nature looks at the evidence for vaccinating younger people.
Wednesday, July 14, 2021
USA Today: Fact check: Yes, viruses can mutate to become more deadly
As the U.S. faces down the COVID-19 Delta variant – now fast-becoming the nation's dominant strain – reports of a new Lambda variant that first emerged in Peru in August 2020 are gaining the attention of public health officials worldwide. News of this coronavirus variant is concerning, especially what it could mean for new COVID-19 cases, hospitalizations and deaths, all of which had been declining in the last few months. But one tweet being shared across social media claims new viral strains are nothing to be worried about.
Thursday, July 08, 2021
Bloomberg News: Dr. Gallo Says COVID-19 Is a Solvable Problem
Dr. Robert Gallo, The Global Virus Network Co-founder and Director at University of Maryland says COVID-19 is a solvable problem, as obviously it was easy to get a solvable vaccine.
Tuesday, July 06, 2021
UM School of Medicine Researchers Receive NIH Avant-Garde Award for Out-Of-Box Concept to Cure HIV and Treat Co-Existing Addiction
Linda Chang, MD, MS, Professor of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine (UMSOM), received the National Institute on Drug Abuse (NIDA) 2021 Avant-Garde Award (DP1) for HIV/AIDS and Substance Use Disorder Research, a National Institutes of Health (NIH) Director’s Pioneer Award. This prestigious award supports researchers with exceptional creativity, who propose high-impact research with the potential to be transformative to the field. She will work with Institute for Human Virology (IHV) researchers for this project.
Saturday, July 03, 2021
India Today: Exclusive: Virologist Dr. Robert Gallo Speaks On Third Wave, Effects On Children & Other COVID Issues
Will India and the world see a third wave, if yes then when? How much the third wave will affect children? If mRNA vaccine is the future of COVID-19 vaccines? World's top virologist, Dr. Robert Gallo, answers these and many other questions related to COVID-19 and its vaccination in an exclusive conversation with Rajdeep Sardesai.
Friday, June 25, 2021
Doctor Radio: What We Know About the Virology of COVID-19
Dr. Marc Siegel talks to the Co-founder & Director of the Institute of Human Virology at the University of Maryland School of Medicine and Co-founder for the Global Virus Network, Dr. Robert Gallo, as well as the President of the Global Virus Network, Dr. Christian Brechot, about COVID-19 Origin, Immunity, Vaccines, and Variants.
Friday, June 25, 2021
Weather Channel: Mystery Thickens Over COVID-19's Origin; Claims of Hidden Early Genetic Information Attracts Further Scrutiny
COVID-19 pandemic has been wreaking worldwide havoc for nearly 20 months now. Yet, Its origin and early spread continue to be one of the most intriguing scientific puzzles of recent history. Claims that the earliest coronavirus strains leaked out from a lab in the Wuhan Institute of Virology in China have resurfaced and subsided multiple times, throughout the course of the pandemic. While many such claims were eventually disregarded as unfounded speculations of conspiracy theorists, allegations have continued against the Wuhan lab having known about the infection and its subsequent threat, much before the world at large was aware.
Tuesday, June 22, 2021
The Washington Post: Wuhan lab’s classified work complicates search for pandemic’s origins
The Wuhan lab has drawn global scrutiny because of its research on bat coronaviruses in the city where the pandemic began. The events have shined a light on a research niche that — in China, the United States and elsewhere — operates with heightened secrecy because of the national security risks of handling deadly pathogens.
Monday, June 21, 2021
Reuters: India should brace for third COVID-19 wave by Oct, say health experts
A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will remain a public health threat for at least another year, according to a Reuters poll of medical experts.
Thursday, June 17, 2021
Big Biology Podcast: Old vaccines for new pandemics (Episode 66)
What has COVID-19 taught us about preparing for future epidemics? Can we trigger innate immune responses – our first lines of defense - to mitigate novel infections? Can we use live-attenuated vaccines (LAV) meant for other infections to protect us while we develop specific vaccines for new pathogens? On this episode, we talk to virologists Konstantin Chumakov and Robert Gallo about their recent paper entitled “Old vaccines for new infections”.
Monday, June 07, 2021
POZ: Integrate Adult and Pediatric HIV Care to Ease Youth Transition to Adult Care
Embedding an adult HIV medicine clinician and care navigator into a Baltimore pediatric HIV clinic led to 95% of young people remaining engaged in adult care one year after transition, according to a report in AIDS Care.
Thursday, June 03, 2021
Slate: A Very Calm Guide to the Lab Leak Theory
More than a year into the COVID-19 pandemic, scientists still aren’t sure where exactly the virus that caused this mess came from, and how it was able to spread so rapidly among humans. With the origins of the coronavirus still up in the air, there’s been a lot of talk of the so-called lab leak theory—the idea that the virus spread to people in a laboratory accident, rather than jumping from a wild animal to a human. In recent days, there’s been a flurry of speculation, and it can be hard to parse what the lab leak theory is all about, how likely it is, and why it matters at all. Here’s our attempt to sort some of that out.
Thursday, May 27, 2021
Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’
A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.
Monday, April 19, 2021
Bloomberg TV: Will Vaccines Protect Us From All Covid-19 Variants?
Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed 141 million, and deaths exceeded 3 million. Gallo speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia."
Monday, April 19, 2021
China Business Network: An interview with Dr. Gallo on COVID-19, Variants and Vaccines
In an exclusive interview with CBN, Dr. Robert Gallo, a world-renowned virus expert, speculated that certain components of Johnson & Johnson and AstraZeneca vaccines may induce the immune system to produce an antibody, which can cause a very small number of people. Heparin-induced thrombocytopenia, thrombosis.
Friday, April 09, 2021
Aljazeera: Which vaccine is best? The one you can get first, experts say
As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus.
Thursday, April 08, 2021
Fox 5 DC: Experts weigh in on timing for second covid-19 vaccine doses
Just how important is timing when it comes to the second dose of the Pfizer and Moderna vaccines? Walgreens is now adjusting its vaccine scheduling process after being asked to do so by the CDC. They were spacing Pfizer vaccines 28 days apart instead of recommended 21 days, because it was just easier to schedule them the same as the Moderna shot.
Friday, April 02, 2021
Baltimore Sun: Q&A with Dr. Robert Gallo: ‘The world has to be linked to fight a pandemic’
Robert Gallo, the eminent virologist best known as co-discoverer of the AIDS virus, says the world needs a system to confront viral disease that’s free of politics and primed to quickly warn nations about new threats as if “the bad Martians are coming.” The uneven and politicized response to the coronavirus pandemic, with a worldwide toll approaching 3 million, including 553,000 deaths in the United States, proves Gallo’s point.
Thursday, April 01, 2021
A Statement from the Leadership of the University of Maryland School of Medicine’s Institute of Human Virology on the Passing of Dr. John Martin
The Institute of Human Virology at the University of Maryland School of Medicine mourns the passing of IHV 2014 Lifetime Achievement Public Service Awardee and 2017 Annual Marlene and Stewart Greenebaum Lecturer, John Martin, PhD. Dr. Martin was a leader in supporting access to life-saving anti-HIV medications that although still under patent were made widely and affordably available to millions around the world infected with HIV, and for prevention through pre-exposure drug therapy. He was a tremendous clinical scientist, businessman, global public health leader, philanthropist, and good friend.
Tuesday, March 30, 2021
USA Today Opinion: Why COVID-19 survivors should only get one dose of mRNA vaccine
Data seems to be indicating that survivors of COVID-19 may not need two doses of mRNA vaccine, which would free up more doses for others.
Tuesday, March 16, 2021
ABC7 WJLA - 7 On Your Side: Doctor rates COVID-19 risks for activities in a partially-vaccinated world
“We see people come in, it's still with really severe disease,” said Dr. Eleanor Wilson, an infectious disease specialist and an associate professor of medicine at the Institute of Human Virology at the University of Maryland School of Medicine.
Sunday, February 21, 2021
The Wall Street Journal: For COVID-19 survivors, one shot may be enough, preliminary studies show
The research, while preliminary, found that the previously infected people generated protection against the disease quickly and at dramatically higher levels after a first shot.
Thursday, February 18, 2021
The Science Advisory Board: The next generation of COVID-19 vaccines: Gallo on next steps
With emergency authorizations for several COVID-19 vaccines under our belt, the question remains if these vaccines will be enough to carry us through the end of the pandemic. Experts agree that there will likely need to be additional vaccines to achieve full recovery. In this two-part series, we discuss what a next-generation COVID-19 vaccine might look like, and which candidates are in the running for authorizations.
Tuesday, February 16, 2021
The Baltimore Sun: Maryland sees little flu this season as researchers wonder if flu vaccine staves off COVID-19
February is typically the cruelest month for the flu with thousands of infections, hundreds hospitalized and some dying in Maryland. Not this year. Due in part to the coronavirus pandemic and preventative measures associated with it, the influenza virus is downright rare in Maryland and across the nation. But researchers are wondering if there’s a chance that the flu shot you got in the fall may yet fend off a nasty infection — of COVID-19.
Friday, February 12, 2021
The Washington Post: Scientists said claims about China creating the coronavirus were misleading. They went viral anyway.
The spread of the unverified assertions by Chinese scholar Li-Meng Yan, widely dismissed as “flawed,” show how vulnerable scientific sites are to misuse and misunderstanding.
Friday, February 12, 2021
China CDC Weekly: Commentary by Dr. Robert C. Gallo
The Great Coronavirus Pandemic of 2019−2021: the Future and the Requirement for China-America Cooperation - Over the past century, the great pandemics and most epidemics (defined as virus presence and disease induction presenting more than the expected number of infections in a population) were caused by the sudden outbreak of an RNA virus such as the pandemics of influenza, polio, and HIV/AIDS and the epidemics of influenza, Ebola, Dengue, Zika, West Nile, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Chikungunya.
Thursday, February 04, 2021
WTOP NEWS: What a new U.Md. study says about skipping second doses of COVID-19 vaccine
None of the trials conducted on the Moderna and Pfizer-BioNTech vaccines tested them on people who already had been infected by the coronavirus. Now, a study involving people previously infected with COVID-19 suggests the immune response from getting sick may act like getting a first dose of those double-shot vaccines.
Tuesday, February 02, 2021
Business Insider: People who had COVID-19 may develop 10 times more antibodies after a single vaccine dose - a sign they might only need one shot
Business Insider - People who had COVID-19 developed at least 10 times more antibodies after their first vaccine dose than the average uninfected person who received two doses, new research shows. Another preliminary study similarly found that healthcare workers who had COVID-19 responded to their first shot the way most people respond to their second. The researchers both suggested that post-COVID patients may only need one shot to sufficiently protect them from the disease again.
Friday, January 22, 2021
Getting treatment early for COVID-19
Baltimore (WBFF) — If you test positive for COVID-19, doctors are reminding you to get treatment right away even if your symptoms aren't bad in the moment. Dr. Anthony Amoroso, infectious disease specialist at the University of Maryland School of Medicine, joins the morning show to talk about why that's important.
Friday, December 11, 2020
Bloomberg TV Asia: Dr. Robert Gallo on COVID-19 Vaccines
Dr. Robert Gallo, co-founder and international scientific advisor of the Global Virus Network and the co-founder and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the rollout of the Covid-19 vaccines. The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers, a step that will likely help clear the way for emergency authorization by the Food and Drug Administration. Gallo, who co-discovered HIV as the cause of AIDS in 1984, speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia." (Source: Bloomberg)
Wednesday, November 11, 2020
Dr. Robert Gallo on Bloomberg Asia on COVID Vaccine Prospects
Dr. Robert C. Gallo, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute of Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, discusses the timeline and safety of Covid-19 vaccine trials. He speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia".
Sunday, November 01, 2020
The Scientist: How Some Vaccines Protect Against More than Their Targets
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
Friday, October 30, 2020
Fox45 News: Contagion figures surrounding Covid-19
Since the beginning of Covid-19, major questions have been asked and some still linger; how long are you contagious and can you be re-infected once you've had the virus Infectious disease physician at the University of Maryland School of Medicine Institute of Human Virology, Dr. Rohit Talwani, joined Fox 45 Morning News Friday to answer those burning questions.
Monday, October 12, 2020
WJLA (Washington, DC): How long can you spread coronavirus once infected? We found out.
Social distancing, hand hygiene and face masks can help curb the spread of the highly contagious coronavirus but if you do get sick, how long can you spread COVID to others? 7 On Your Side went looking for answers.
Friday, August 28, 2020
WYPR: Could Polio Vaccine Corral Covid-19?
A safe, effective vaccine against Covid-19 could resurrect jobs, send kids back to classrooms--change our lives. But how safe and effective? And how quickly can we have it? Dr. Robert Gallo, the AIDS-research pioneer now leading virus science at the Institute of Human Virology at the University of Maryland School of Medicine and the Global Virus Network, argues we could get much of the benefit by inoculating people with an old, very cheap drug -- the oral Polio vaccine developed seven decades ago. Gallo contends it would trigger our ‘innate immunity’-- the body’s emergency response when a threat shows up.
Friday, August 21, 2020
Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.
Monday, August 03, 2020
Eureka, Charles River Laboratories: Could the Oral Polio Vaccine be Used to Prevent COVID-19?
Virologist Robert Gallo, MD, has had a long and storied career in academic and government research. He is the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology (IHV) at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. Despite his deep roots in HIV, Dr. Gallo’s current focus is, not surprisingly, COVID-19, which emerged in China last year and within four months morphed into a full-blown pandemic. As usual, Dr. Gallo’s research strategy has raised eyebrows. Unlike the antibody and RNA vaccines that are all the rage in COVID-19 science, Gallo is putting his energies behind repurposing the oral polio virus vaccine developed in the 1950s by Albert Sabin.
Monday, August 03, 2020
Infectious Disease Special Edition: COVID-19 and HIV: Was It a Deadly Mix?
Social distancing is one of the curses of COVID-19, and may fall more heavily on people with HIV than on those without this burden. “People with HIV, and in particular certain subsets of that group—the LGBTQ community, older adults aging with HIV, etc.—face more mental health issues than the general population,” said Sarah Schmalzle, MD, an assistant professor of medicine at the Institute of Human Virology, University of Maryland School of Medicine, in Baltimore. “Many of our patients also already face significant isolation and loneliness due to a combination of HIV stigma, losses of friends and family to HIV, and aging.”
Friday, July 31, 2020
RollingStone-Useful Idiots: Dr. Robert Gallo on a COVID-19 Vaccine
Dr. Robert Gallo, director of the Institute for Human Virology at the University of Maryland School of Medicine, joins the show to give his take on the prospects for an effective COVID-19 vaccine. Gallo is skeptical of the approach many organizations are taking with antibody vaccines, citing the similarly low efficacy those treatments had with HIV due to the low durability of the antibodies. Dr. Gallo’s research is mainly related to Oral Polio Vaccine, which he thinks needs to be tested more in regard to innate immunity.
Friday, July 24, 2020
A Statement from the Leadership of the Institute of Human Virology and the Global Virus Network on the Passing of Renowned Chinese Virologist Yi Zeng
The IHV at the University of Maryland School of Medicine and the Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 32 countries, collectively mourns the passing of Professor Yi Zeng, MD, Academician of the Chinese Academy of Sciences, former President of the Chinese Academy of the Preventive Medicine and former Dean of the College of Life Science and Bioengineering at Beijing University of Technology.
Monday, July 20, 2020
NPR: Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say
Dr. Robert Gallo is quoted about an experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 that triggered an immune response against the coronavirus and appeared to be safe.
Monday, July 06, 2020
Sputnik Radio: What If There Is No Vaccine for COVID-19?
On today's episode of Loud & Clear, Brian Becker and John Kiriakou are joined by Robert Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. What would you think if someone told you that we already have a vaccine that at least helps fight Covid-19? That may already be the case. Two American scientists, Dr. Robert Gallo and Dr. Konstantin Chumakov, are positing that decades-old live vaccines for things like polio and tuberculosis strengthen the immune system’s first line of defense a more general way to fight infection. And the history books show us that that sometimes translates into at least some cross-protection against completely different viruses.
Friday, July 03, 2020
KUSI San Diego News: Dr. Robert Gallo suggests an oral polio vaccine could help fight coronavirus
Dr. Robert Gallo from the Institute of Human Virology at the University of Maryland School of Medicine and Global Virus Network wrote an op-ed in the Wall Street Journal earlier this week. The opinion piece stated that OPV, oral polio vaccine, could be a cheap and effective way to fight coronavirus. Dr. Gallo discussed his opinion piece on Good Morning San Diego.
Thursday, July 02, 2020
13D Global Strategy & Research Report
COVID-19 outbreaks are multiplying and immunity may be short-lived. Could existing “live” vaccines, which stimulate innate immunity, outshine vaccines targeting the “spike” protein?
Tuesday, June 30, 2020
Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.
In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”
Monday, June 29, 2020
Baltimore Magazine Special Edition: Dr. Gallo Featured
Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."
Friday, June 26, 2020
IHV in the News
Links to news stories featuring the IHV from June 11 to June 25, 2020.
Thursday, June 25, 2020
The New York Times: Dr. Robert Gallo: The Case for a Stopgap Vaccine
In a letter to the editor to The New York Times entitled, "Dr. Robert Gallo: The Case for a Stopgap Vaccine," the noted virologist and head of the IHV says a polio vaccine may be an ideal solution until we find a Covid-specific vaccine.
Wednesday, June 24, 2020
The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy
The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy: A married pair of virologists in Moscow tested a vaccine on their own children in the 1950s. Now, a side effect they found is sparking new hope for a defense against the coronavirus.
Tuesday, June 23, 2020
France 24: Dr. Mohammad Sajadi Speaks with France 24 on COVID-19 and Seasonality
Does Covid-19 spread faster in winter? Modelling by US researchers suggests the transmission of Covid-19 could be seasonal. Mohammad Sajadi, associate professor at University of Maryland School of Medicine's Institute of Human Virology, says the virus first spread in areas of low temperature and low humidity, common to winter time in temperate areas.
Friday, June 12, 2020
Institute of Human Virology and Italian Researchers Find Higher Daily Temperatures Lead to a Decrease in COVID-19 Related Deaths
Insights into population density and daily temperatures provide a path to public health strategies. The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome and Ulisse Biomed and University of Trieste, in Trieste, Italy announced today the results of studies showing an inverse correlation between average high daily temperatures and COVID-19 related death rates in different geographical areas.
Friday, June 12, 2020
The Washington Post: We shouldn’t care who wins the vaccine ‘race’
Dr. Robert Gallo writes a Letter to the Editor to The Washington Post entitled, “We shouldn’t care who wins the vaccine ‘race’,” regarding their June 4 front-page article “Cold War echoes in race for vaccine,” about the “race” among nations, notably the United States, China, and Russia and other European nations for development of a vaccine against the novel coronavirus.
Friday, June 12, 2020
CNN Health: An Existing Polio Vaccine Could Help Protect Against Coronavirus, Top Experts Say
CNN: There is plenty of evidence that existing inoculations such as polio vaccines protect children against a wide range of infections and it's worth trying them out against the new coronavirus, a team of experts wrote in Science magazine Thursday.
Thursday, June 11, 2020
NBC News: Polio Vaccine Could Give Temporary Protection Against COVID-19, Scientists Hope
NBC News: As the world waits for a coronavirus vaccine, some scientists are proposing that existing vaccines could give the body’s immune system a much-needed temporary boost to stave off infection. It’s still unclear whether such an approach would work, and some experts are skeptical. Others — including researchers in Israel, the Netherlands and Australia — are already investigating whether a tuberculosis vaccine could help jump-start the immune system and make COVID-19 less deadly, though the World Health Organization strongly advises against using that vaccine until it’s proven effective against the coronavirus.